Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

ražots eiropas savienībā pēc large life limited (lielbritānija) pasūtījuma - pulveris

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

ražots eiropas savienībā pēc large life limited (lielbritānija) pasūtījuma - šķidrums

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

ražots eiropas savienībā pēc large life limited (lielbritānija) pasūtījuma - pulveris

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridīns - multiplā skleroze - other nervous system drugs - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

biocryst ireland limited - berotralstat dihydrochloride - angioedēma, iedzimta - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

amivas ireland ltd - artesunāts - malārija - antiprostozie līdzekļi - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. jāņem vērā oficiālās vadlīnijas par pareizi lietot pretmalārijas aģentu.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

bial portela & companhia s.a. - opikapons - parkinsona slimība - anti-parkinsona zāles - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Latvija - latviešu - Zāļu valsts aģentūra

menarini international operations luxembourg s.a., luxembourg - bilastīns - acu pilieni, šķīdums - 6 mg/ml

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - kolīts, čūlas - imūnsupresanti - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.